Drug recall · July 30, 2025
Epinephrine Lidocaine HCL recall
Why: Sub-Potent Drug: Subpotent assay results during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01
- Lots / codes
Lot: 24DEC017, Exp. 07/12/2025.
- Quantity
- 6,880 vials
- Company
- Imprimis NJOF, LLC, Ledgewood, NJ
- Distribution
- Nationwide in the USA
- Initiated
- July 9, 2025 · Voluntary: Firm initiated
- Classified
- July 21, 2025
- Reported
- July 30, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.